煙草在線據(jù)NACS報(bào)道編譯　　3月6日，美國食品與藥品監(jiān)督管理局（FDA）的零售商研討會(huì)僅僅討論了小型業(yè)主提出的關(guān)于FDA煙草法規(guī)的一些最常見問題。該次會(huì)議并未披露任何新的信息，僅簡(jiǎn)單重申了煙草零售商的法律義務(wù)。以下是研討會(huì)內(nèi)容概覽：

　　·廣告：卷煙廣告不能包含“淡味”、“超淡味”等形容詞描述，且必須包含衛(wèi)生部的健康警示內(nèi)容。

　　·圖片警語標(biāo)簽：根據(jù)2月底訴訟法庭的裁決，FDA要求卷煙包裝印刷圖片警語的規(guī)定是違憲的，在訴訟作出最終裁決前并不期望煙草零售商和制造商們執(zhí)行此規(guī)定。

　　·免費(fèi)樣品：零售商不能提供卷煙的免費(fèi)樣品，而無煙煙草產(chǎn)品的免費(fèi)樣品僅允許在禁止18歲以下青少年進(jìn)入的店鋪中提供。

　　·贈(zèng)品：除卷煙或無煙煙草產(chǎn)品打折出售外，零售商禁止向購買卷煙或無煙煙草產(chǎn)品者提供任何贈(zèng)品或優(yōu)惠（免費(fèi)火柴除外）。同時(shí)，零售商不得向非煙草產(chǎn)品購買者（例如汽油購買者）提供任何卷煙或無煙煙草產(chǎn)品的打折優(yōu)惠。FDA向全國大學(xué)商店協(xié)會(huì)（NACS）指出，消費(fèi)者或許會(huì)通過購買卷煙或無煙煙草產(chǎn)品要求記錄其“忠誠度”，但零售商不能以任何“忠誠度累計(jì)”或類似的項(xiàng)目記錄消費(fèi)者購買卷煙或無煙煙草產(chǎn)品的次數(shù)。

　　·電子卷煙：去年對(duì)于電子卷煙并非“藥品或醫(yī)藥設(shè)備”因此不遵守這些產(chǎn)品嚴(yán)格的法律措施的此法裁決，盡管FDA沒有提起上訴，但是FDA仍然有權(quán)對(duì)電子卷煙制定與卷煙產(chǎn)品類似的法律法規(guī)，也不排除將來出臺(tái)此類法規(guī)的可能性。

　　FDA并未宣布下一次煙草零售商研討會(huì)召開的時(shí)間和地點(diǎn)。您若錯(cuò)過了3月6日的研討會(huì)，可以在FDA網(wǎng)站觀看在線視頻。

　　如果您想了解更多關(guān)于FDA民事賠償程序，或零售商的職責(zé)及遵守要求等內(nèi)容，請(qǐng)注冊(cè)參加3月14日由NACS和We Card主辦的研討會(huì)。

FDA Reiterates Tobacco Retailers' Obligations

NACS
Mar 7, 2012

　　The Food and Drug Administration (FDA) webinar for retailers reviewed some of the most frequently asked questions small businesses have asked regarding FDA's tobacco regulations. The March 6 webinar did not reveal any new information, but simply reiterated tobacco retailers' legal obligations. Here is an overview:

　　·Advertisements: Cigarette advertisements may not include descriptors ("light," "ultra-light," etc.) and must include the Surgeon General's warning.

　　·Graphic warning labels: In light of last week's litigation court ruling that FDA's requirements for graphic warning labels on cigarette packages were unconstitutional, tobacco retailers and manufacturers are not expected to comply with that rule's mandates during the pending litigation.

　　·Free Samples: Retailer may not distribute free samples of cigarettes, and free samples of smokeless tobacco may only be distributed in facilities where minors under the age of 18 are not permitted to enter.

　　·Gifts: Retailers are prohibited from offering any benefit to a customer in return for purchasing cigarettes or smokeless tobacco (except for free matches) unless that benefit is discounted cigarettes or smokeless tobacco. Also, retailers may not offer discounted cigarettes or smokeless tobacco in return for any non-tobacco purchase (such as gasoline). FDA has indicated to NACS, however, that customers may redeem "loyalty points" by buying cigarettes or smokeless tobacco, but retailers may not count purchases of cigarettes or smokeless tobacco as points in any such loyalty or affinity program.

　　·E-Cigarettes: Although FDA did not appeal last year's judicial ruling that e-cigarettes are not "drugs or devices" and thus not subject to those products' strict regulatory treatment, FDA indicated that it has the authority to issue regulations regulating e-cigarettes as cigarettes, and that it may propose such regulations in the future.

　　FDA has not announced when its next tobacco compliance webinar for retailers will take place. If you missed the March 6 webinar, it is online.

　　If you want to learn more about how to navigate FDA's Civil Monetary Penalty Process and better understand retailer responsibilities and compliance requirements, register for the free March 14 webinar sponsored by NACS and We Card.